Enzymatica
Enzymatica's CFO leaves his role
The Science Behind ColdZyme – Insights from Professors
A study with athletes has shown that Enzymaticas...
News roundup Thursday, May 8
S2Medical
Enzymatica gears up for global expansion after strong first quarter
During the first quarter, Enzymatica increased net sales by 30,3...
News roundup Tuesday, April 29
AstraZeneca
News roundup Thursday, April 10
Implantica
News roundup Thursday, April 3
Faron Pharmaceuticals
Enzymatica's results are published in The Journal of Physiology
Study results show that Enzymatica's ColdZyme mouth spray reduces the amount of virus...
News roundup Friday, March 7
Cancer
News roundup Monday, March 3
AbbVie
Increased revenue in Q4 but potential for better partner sales for Enzymatica
The cold season is underway and it is also visible in...
News roundup Tuesday, February 18
AlzeCure
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
